In­side PBM­s' tac­tics to tilt the mar­ket; Is the KRAS race still on? CAR-T safe­ty scares trig­ger halts; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

We are, thank­ful­ly, head­ed in­to a three-day week­end here at End­points News. For those of you who fol­low the dai­ly re­ports, see you on Tues­day. Oth­er­wise, en­joy the rest and this re­port will hit your in­box again next Sat­ur­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.